Concise Review: The Role of C‐kit Expressing Cells in Heart Repair at the Neonatal and Adult Stage

Ischemic heart disease is the number one cause of morbidity and mortality in the developed world due to the inability of the heart to replace lost myocytes. The cause of postinfarction myogenic failure has been a subject of intense scientific investigation and much controversy. Recent data indicate...

Full description

Saved in:
Bibliographic Details
Published inStem cells (Dayton, Ohio) Vol. 32; no. 7; pp. 1701 - 1712
Main Authors Hesse, Michael, Fleischmann, Bernd K., Kotlikoff, Michael I.
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 01.07.2014
Subjects
Online AccessGet full text
ISSN1066-5099
1549-4918
1549-4918
DOI10.1002/stem.1696

Cover

More Information
Summary:Ischemic heart disease is the number one cause of morbidity and mortality in the developed world due to the inability of the heart to replace lost myocytes. The cause of postinfarction myogenic failure has been a subject of intense scientific investigation and much controversy. Recent data indicate a brief perinatal developmental window exists during which postinfarction myogenesis, and substantial heart regeneration, occurs. By contrast, repair of an equivalent injury of the adult heart results in prominent revascularization without myogenesis. Here, we review recent experiments on neonatal postinjury myogenesis, examine the mechanistic hypotheses of dedifferentiation and precursor expansion, and discuss experiments indicating that postinfarction revascularization derives primarily from cardiac vascular precursors. These data have profound consequences for the understanding of human heart repair, as they address the long standing question as to whether human postinfarction myogenic failure is due to the loss of precursors existent at the neonatal stage or to a context‐dependent inhibition of these precursors within the infarct, and suggest strategies for the recapitulation of neonatal myogenic capacity and the augmentation of revascularization. Stem Cells 2014;32:1701–1712
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1066-5099
1549-4918
1549-4918
DOI:10.1002/stem.1696